Pont-du-Château, November 15, 2024 – Dômes Pharma Group has officially renamed SentrX Animal Care as Dômes Pharma, Inc. in the U.S., strengthening its global brand presence. This rebranding aligns with the company’s vision of expanding its global leadership in veterinary ophthalmology and therapeutic specialties. In addition, Dômes Pharma has acquired the NeoPolyBac ointment Veterinary label from Akorn Pharmaceuticals, a triple antibiotic ophthalmic product with a long history of sales and support in the U.S.. “We are delighted to have the U.S. division aligned with our global brand. Veterinarians are engaging with our products, research and technical support on a global level. This change will ensure a consistent experience no matter where they engage with us.” said Anne Moulin, President of Dômes Pharma US. “In addition, the acquisition of NeoPolyBac and the actions we are taking to re-establish manufacturing...